{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:20:57Z","timestamp":1793042457628,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:00:00Z","timestamp":1606348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Complementary Therapies in Medicine"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ctim.2020.102635","type":"journal-article","created":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T12:41:50Z","timestamp":1606740110000},"page":"102635","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Efficacy of resveratrol supplementation on liver enzymes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"57","author":[{"given":"Shumin","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ctim.2020.102635_bib0005","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease\u2013A global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.ctim.2020.102635_bib0010","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.ctim.2020.102635_bib0015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.ctim.2020.102635_bib0020","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"issue":"27","key":"10.1016\/j.ctim.2020.102635_bib0025","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.3748\/wjg.v24.i27.2974","article-title":"Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From \u201ctwo hit theory\u201d to \u201cmultiple hit model\u201d","volume":"24","author":"Fang","year":"2018","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.ctim.2020.102635_bib0030","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.dsx.2018.03.016","article-title":"Non-alcoholic fatty liver disease and associated dietary and lifestyle risk factors","volume":"12","author":"Rayyan","year":"2018","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.ctim.2020.102635_bib0035","series-title":"Obesity, fatty liver and liver Cancer","first-page":"149","article-title":"Current prevention and treatment options for NAFLD","author":"Wong","year":"2018"},{"issue":"10","key":"10.1016\/j.ctim.2020.102635_bib0040","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.tem.2019.07.013","article-title":"Are lifestyle therapies effective for NAFLD treatment?","volume":"30","author":"El-Agroudy","year":"2019","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ctim.2020.102635_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154183","article-title":"Established and emerging factors affecting the progression of nonalcoholic fatty liver disease","author":"Kechagias","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.ctim.2020.102635_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2019.154001","article-title":"Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: Think out of the box!","volume":"101","author":"Ranjbar","year":"2019","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.ctim.2020.102635_bib0055","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/biomedicines6030091","article-title":"Resveratrol: A double-edged sword in health benefits","volume":"6","author":"Salehi","year":"2018","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.ctim.2020.102635_bib0060","first-page":"1","article-title":"The therapeutic potential of resveratrol: A review of clinical trials","volume":"1","author":"Berman","year":"2017","journal-title":"Npj Precis Oncol"},{"issue":"5","key":"10.1016\/j.ctim.2020.102635_bib0065","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3390\/nu8050250","article-title":"Resveratrol and cardiovascular diseases","volume":"8","author":"Bonnefont-Rousselot","year":"2016","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.ctim.2020.102635_bib0070","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.nutres.2014.09.005","article-title":"Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease","volume":"34","author":"Faghihzadeh","year":"2014","journal-title":"Nutr Res"},{"issue":"3","key":"10.1016\/j.ctim.2020.102635_bib0075","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.dld.2014.11.015","article-title":"Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial","volume":"47","author":"Chen","year":"2015","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.ctim.2020.102635_bib0080","doi-asserted-by":"crossref","DOI":"10.3109\/00365521.2015.1107620","article-title":"Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease","author":"Heeb\u00f8ll","year":"2016","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"10.1016\/j.ctim.2020.102635_bib0085","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/07315724.2017.1392264","article-title":"Comparison of calorie-restricted diet and resveratrol supplementation on anthropometric indices, metabolic parameters, and serum sirtuin-1 levels in patients with nonalcoholic fatty liver disease: A randomized controlled clinical trial","volume":"37","author":"Asghari","year":"2018","journal-title":"J Am Coll Nutr"},{"issue":"7","key":"10.1016\/j.ctim.2020.102635_bib0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.ctim.2020.102635_bib0095","series-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2019"},{"issue":"12","key":"10.1016\/j.ctim.2020.102635_bib0100","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.cgh.2014.02.024","article-title":"Resveratrol does not benefit patients with nonalcoholic fatty liver disease","volume":"12","author":"Chachay","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ctim.2020.102635_bib0105","first-page":"e13692","article-title":"Effects of resveratrol supplementation on liver enzymes: A systematic review and meta\u2010analysis of randomised controlled trials","author":"Darand","year":"2020","journal-title":"Int J Clin Pract"},{"issue":"3","key":"10.1016\/j.ctim.2020.102635_bib0110","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s11695-007-9295-8","article-title":"The utility of the \u201cNAFLD fibrosis score\u201d in morbidly obese subjects with NAFLD","volume":"18","author":"Qureshi","year":"2008","journal-title":"Obes Surg"},{"issue":"10","key":"10.1016\/j.ctim.2020.102635_bib0115","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.tem.2008.08.005","article-title":"Insulin resistance, inflammation, and non-alcoholic fatty liver disease","volume":"19","author":"Tilg","year":"2008","journal-title":"Trends Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ctim.2020.102635_bib0120","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.clinthera.2018.05.015","article-title":"Effect of resveratrol supplementation on inflammatory markers: A systematic review and meta-analysis of randomized controlled trials","volume":"40","author":"Koushki","year":"2018","journal-title":"Clin Ther"},{"issue":"4","key":"10.1016\/j.ctim.2020.102635_bib0125","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3390\/nu11040872","article-title":"Oxidative stress and non-alcoholic fatty liver disease: Effects of omega-3 fatty acid supplementation","volume":"11","author":"Yang","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.ctim.2020.102635_bib0130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2036.2005.02601.x","article-title":"Role of oxidative stress in the progression of non\u2010alcoholic steatosis","volume":"22","author":"Albano","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.ctim.2020.102635_bib0135","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/j.1478-3231.2010.02295.x","article-title":"Resveratrol and liver disease: From bench to bedside and community","volume":"30","author":"Bishayee","year":"2010","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.ctim.2020.102635_bib0140","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0168-8278(03)00479-3","article-title":"Overweight and obesity, hepatic steatosis, and progression of chronic hepatitis C: a retrospective study on a large cohort of patients in the United States","volume":"40","author":"Hu","year":"2004","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.ctim.2020.102635_bib0145","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1002\/oby.21580","article-title":"Metabolically healthy obesity is associated with an increased risk of diabetes independently of nonalcoholic fatty liver disease","volume":"24","author":"Chang","year":"2016","journal-title":"Obesity"},{"issue":"3","key":"10.1016\/j.ctim.2020.102635_bib0150","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/10408398.2018.1529654","article-title":"The effects of resveratrol intake on weight loss: A systematic review and meta-analysis of randomized controlled trials","volume":"60","author":"Tabrizi","year":"2020","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"4","key":"10.1016\/j.ctim.2020.102635_bib0155","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3390\/nu9040387","article-title":"Nonalcoholic fatty liver disease and insulin resistance: New insights and potential new treatments","volume":"9","author":"Kitade","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.ctim.2020.102635_bib0160","first-page":"S61","article-title":"Therapy of NAFLD: Insulin sensitizing agents","volume":"40","author":"Caldwell","year":"2006","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"10.1016\/j.ctim.2020.102635_bib0165","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.3945\/ajcn.113.082024","article-title":"Effect of resveratrol on glucose control and insulin sensitivity: A meta-analysis of 11 randomized controlled trials","volume":"99","author":"Liu","year":"2014","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.ctim.2020.102635_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2008.08.001","article-title":"Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)","volume":"48","author":"Musso","year":"2009","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.ctim.2020.102635_bib0175","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.phrs.2017.12.033","article-title":"Effect of resveratrol on lipid profile: An updated systematic review and meta-analysis on randomized clinical trials","volume":"129","author":"Haghighatdoost","year":"2018","journal-title":"Pharmacol Res"}],"container-title":["Complementary Therapies in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229920319026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229920319026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:14:38Z","timestamp":1760807678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0965229920319026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":35,"alternative-id":["S0965229920319026"],"URL":"https:\/\/doi.org\/10.1016\/j.ctim.2020.102635","relation":{},"ISSN":["0965-2299"],"issn-type":[{"value":"0965-2299","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of resveratrol supplementation on liver enzymes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Complementary Therapies in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctim.2020.102635","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102635"}}